-
Ligand Pharmaceuticals Reports Earnings; Lemelson Capital Adds To Short Position
Monday, August 4, 2014 - 3:45pm | 136Read More...Ligand Pharmaceuticals (NASDAQ: LGND) is trading up almost 10 percent following its earnings release and news that Lemelson Capital Management has further increased its short position in the company. Chief Investment Officer Emmanuel Lemelson stated, "Ligand's 76 percent plunge in EPS...
-
#PreMarket Prep Guest List For The Week of June 16, 2014
Friday, June 13, 2014 - 4:34pm | 1229Read More...A full week of guests is ahead for Benzinga's #PreMarket Prep broadcast, sponsored by OptionsHouse. Tune in at 8:00 am EST Monday-Friday here for market analysis and insight. Monday, June 16, 8:35 a.m. Anthony Alfidi (@tonyalfidi), Founder and CEO of Alfidi Capital Alfidi Capital...
